Rodney J Ellis Selected Research

Capromab Pendetide

9/2011	Ten-year outcomes: the clinical utility of single photon emission computed tomography/computed tomography capromab pendetide (Prostascint) in a cohort diagnosed with localized prostate cancer.
4/2007	Rectal morbidity after permanent prostate brachytherapy with dose escalation to biologic target volumes identified by SPECT/CT fusion.
7/2004	Role of ProstaScint for brachytherapy in localized prostate adenocarcinoma.
10/2003	Four-year biochemical outcome after radioimmunoguided transperineal brachytherapy for patients with prostate adenocarcinoma.
1/2003	Combination conformal radiotherapy and radioimmunoguided transperineal 103Pd implantation for patients with intermediate and unfavorable risk prostate adenocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rodney J Ellis Research Topics

Disease

14	Neoplasms (Cancer) 01/2018 - 10/2002
12	Prostatic Neoplasms (Prostate Cancer) 01/2018 - 01/2003
4	Adenocarcinoma 04/2007 - 01/2003
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020 - 04/2013
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021 - 11/2019
2	Renal Cell Carcinoma (Grawitz Tumor) 11/2020 - 03/2014
2	Liver Neoplasms (Liver Cancer) 11/2014 - 05/2014
2	Neoplasm Metastasis (Metastasis) 05/2014 - 12/2012
1	Kidney Neoplasms (Kidney Cancer) 03/2016
1	Rectovaginal Fistula 01/2015
1	Hepatocellular Carcinoma (Hepatoma) 11/2014
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2014
1	Lung Neoplasms (Lung Cancer) 12/2012
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 09/2012
1	Carcinoma (Carcinomatosis) 09/2012
1	Residual Neoplasm 09/2012
1	Acquired Immunodeficiency Syndrome (AIDS) 10/2002
1	Hemospermia 10/2002

Drug/Important Bio-Agent (IBA)

5	Capromab Pendetide FDA Link 09/2011 - 01/2003
3	AndrogensIBA 01/2018 - 10/2002
3	Biological ProductsIBA 09/2011 - 01/2003
2	MetalsIBA 07/2015 - 09/2012
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2021
1	Gemcitabine FDA Link 01/2015
1	Carboplatin (JM8)FDA LinkGeneric 01/2015
1	AntigensIBA 07/2004
1	Glycoproteins (Glycoprotein)IBA 07/2004
1	SteroidsIBA 10/2002
1	AntidiarrhealsIBA 10/2002
1	Hormones (Hormone)IBA 10/2002

Therapy/Procedure

19	Radiotherapy 11/2020 - 10/2002
12	Brachytherapy 11/2019 - 01/2003
5	Therapeutics 01/2018 - 01/2009
4	Drug Therapy (Chemotherapy) 05/2016 - 09/2012
2	Prostatectomy (Retropubic Prostatectomy) 01/2018 - 01/2009
1	Proton Therapy 01/2018
1	Palliative Care (Palliative Therapy) 01/2015
1	Aftercare (After-Treatment) 09/2012
1	Image-Guided Radiotherapy 09/2011
1	Conformal Radiotherapy 01/2003
1	Lasers (Laser) 10/2002